Fintel reports that on May 9, 2025, B of A Securities downgraded their outlook for Apellis Pharmaceuticals (NasdaqGS:APLS) ...

Fintel reports that on May 9, 2025, Raymond James downgraded their outlook for Apellis Pharmaceuticals (NasdaqGS:APLS) from ...

L’intelligenza artificiale ridefinisce lavoro, competenze e occupazione. Il lavoro bionico è la sfida da affrontare ora.

Sicurezza sul lavoro: in Sardegna parte il primo corso online obbligatorio per datori di lavoro, firmato 626 School ...

Dalla sconfitta contro il Modena emerge con prepotenza un altro tema in casa Bari: l’impiego di Andrea Favilli. L’attaccante ...

Several hedge funds have recently made changes to their positions in ARWR. Avoro Capital Advisors LLC raised its holdings in Arrowhead Pharmaceuticals by 25.0% in the 4th quarter. Avoro Capital ...

Kymera Therapeutics announced new clinical trials for KT-621, targeting atopic dermatitis and asthma, with data expected in 2025 and 2026. Kymera Therapeutics has announced the initiation of ...

Avoro Capital Advisors holds 2,760K shares representing 6.15% ownership of the company. In its prior filing, the firm reported owning 2,859K shares , representing a decrease of 3.57%. The firm ...

Pisa, 18 aprile 2025 – “Uno studio dei giovani per i giovani”. La nuova segretaria provinciale Cisl, Giorgia Bumma, ha introdotto così la ricerca di Jevis (Junior Enterprise Pisa ...